About Iffat Pharmaceuticals
Iffat Pharmaceuticals is a Healthcare company. Manufacturing and distributing pharmaceutical medicines globally. Its Indian entity Iffat Pharmaceuticals Private Limited reported revenue of ₹15.5 Lakh. Iffat Pharmaceuticals offers products and services including Aciful-MP Oral Suspension and REBISAC-DSR. Its focus areas include Pharmaceuticals, Drug Distribution, Global Supply Chain and Medicine Manufacturing.
Company details
Iffat Pharmaceuticals Private Limited is identified as a privately held global pharmaceutical company that engages in the production of a diverse array of quality medicines. Its mission is noted for the provision of innovative healthcare relief while ethical standards are upheld in operations. The vision involves ensuring that affordable, high-quality medicines are made accessible worldwide, with products such as oral suspensions and tablets being manufactured for various health needs. Operations are based in Mumbai, India, facilitating global reach through stringent processes.
- SectorsHealthcare
- Email••••••••
- Legal Name Iffat Pharmaceuticals Private Limited
- Date of Incorporation 18 Sep, 2015
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹15.5 Lakh
FY 2024 · -8% YoY
- Indian entity net loss-₹20,594
FY 2024 · -1% margin
- Indian entity EBITDA-₹20,594
FY 2024 · -1% margin
Associated legal entities of Iffat Pharmaceuticals
Iffat Pharmaceuticals operates through Iffat Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Iffat Pharmaceuticals Private Limited CIN U74999MH2015PTC268514 | Active | 18 Sep 2015 | Mumbai, Maharashtra | ₹0.2 Cr | 2 | View details |
Products & Services of Iffat Pharmaceuticals
Iffat Pharmaceuticals offers a comprehensive portfolio of products and services, including Aciful-MP Oral Suspension and REBISAC-DSR.
This oral suspension is produced for pain relief and is composed of Mefenamic Acid and Paracetamol.
This tablet is formulated for gastrointestinal issues and includes Domperidone and Rabeprazole.
Board of directors of Iffat Pharmaceuticals Private Limited (Iffat Pharmaceuticals)
Iffat Pharmaceuticals Private Limited is the primary company behind Iffat Pharmaceuticals. The board of Iffat Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Faiza Iffat, appointed in 2015.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Faiza Iffat DIN 07278571 | Director | 18 Sep 2015 | 11 yrs 1 mo | Iffat Pharmaceuticals Private Limited |
| Nesar Ahmad DIN 07278580 | Director | 18 Sep 2015 | 11 yrs 1 mo | Iffat Pharmaceuticals Private Limited |
Financials of Iffat Pharmaceuticals
Figures of Iffat Pharmaceuticals Private Limited, the primary company behind Iffat Pharmaceuticals, for FY 2024. Revenue was ₹15.5 Lakh (-8% year on year). Net loss was -₹20,594 (-1% margin). EBITDA was -₹20,594 (-1% margin). Revenue has grown at a compounded annual rate of +43% over three years and +38% over five years.
- ₹15.5 LakhRevenue · FY 2024 · -8% YoY
- -₹20,594Net loss · -1% margin
- -₹20,594EBITDA · -1% margin
- ₹1 LakhPaid-up capital
- +43%Revenue CAGR, 3 years
- +38%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Iffat Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Iffat Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Iffat Pharmaceuticals
The primary company behind Iffat Pharmaceuticals, Iffat Pharmaceuticals Private Limited, reported revenue of ₹15.5 Lakh for FY 2024, down 8% year on year.
Iffat Pharmaceuticals Private Limited is identified as a privately held global pharmaceutical company that engages in the production of a diverse array of quality medicines. Its mission is noted for the provision of innovative healthcare relief while ethical standards are upheld in operations. The vision involves ensuring that affordable, high-quality medicines are made accessible worldwide, with products such as oral suspensions and tablets being manufactured for various health needs. Operations are based in Mumbai, India, facilitating global reach through stringent processes.
Iffat Pharmaceuticals offers Aciful-MP Oral Suspension and REBISAC-DSR.
Iffat Pharmaceuticals operates through Iffat Pharmaceuticals Private Limited.
The legal entities of Iffat Pharmaceuticals currently have 2 directors, including Faiza Iffat, Nesar Ahmad.